Literature DB >> 18305041

Dominant negative inhibition of human immunodeficiency virus particle production by the nonmyristoylated form of gag.

Shigeo Kawada1, Toshiyuki Goto, Hiyori Haraguchi, Akira Ono, Yuko Morikawa.   

Abstract

Myristoylation of human immunodeficiency virus (HIV) Gag protein is essential for membrane targeting of Gag and production of viral particles. We show here that coexpression of wild-type and nonmyristoylated forms of HIV Gag resulted in severe inhibition of viral particle production, indicating that the nonmyristoylated counterpart had a dominant negative effect on particle release. When coexpressed, the nonmyristoylated Gag partially incorporated into membrane and lipid raft fractions, likely through coassembly with the wild-type Gag. The membrane and raft associations of the wild-type Gag appeared unaffected, and yet particle production was severely impaired. When viral particles produced from the coexpressing cells were analyzed, the wild-type Gag was more abundant than the nonmyristoylated Gag. Confocal microscopy showed that both forms of Gag were diffusely distributed in the cytoplasm of coexpressing cells but that a portion of the wild-type Gag population was accumulated in EEA1- and CD63-positive endosomes. The intracellular accumulation of Gag was more frequently observed at late time points. The Gag accumulation was also observed on the cell surface protrusion. Electron microscopy of the coexpressing cells revealed budding arrest phenotypes, including the occurrence of interconnected virions on the plasma membrane, and intracellular budding. We also show that the inhibition of particle production and the Gag accumulation to endosomes were suppressed when the nucleocapsid (NC) domain was deleted from the nonmyristoylated Gag, although the NC-deleted Gag was still capable of coassembly. Overall, our data indicate that coassembly with the nonmyristoylated Gag impairs HIV particle release, a phenomenon that may involve NC-mediated Gag-Gag interaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305041      PMCID: PMC2293052          DOI: 10.1128/JVI.01953-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  Entropic switch regulates myristate exposure in the HIV-1 matrix protein.

Authors:  Chun Tang; Erin Loeliger; Paz Luncsford; Isaac Kinde; Dorothy Beckett; Michael F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

2.  HIV-1 egress is gated through late endosomal membranes.

Authors:  Sascha Nydegger; Michelangelo Foti; Aaron Derdowski; Paul Spearman; Markus Thali
Journal:  Traffic       Date:  2003-12       Impact factor: 6.215

3.  Visualization of retroviral replication in living cells reveals budding into multivesicular bodies.

Authors:  Nathan M Sherer; Maik J Lehmann; Luisa F Jimenez-Soto; Alyssa Ingmundson; Stacy M Horner; Gregor Cicchetti; Philip G Allen; Marc Pypaert; James M Cunningham; Walther Mothes
Journal:  Traffic       Date:  2003-11       Impact factor: 6.215

4.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane association.

Authors:  Mariam Andrawiss; Yasuhiro Takeuchi; Lindsay Hewlett; Mary Collins
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  An early stage of Mason-Pfizer monkey virus budding is regulated by the hydrophobicity of the Gag matrix domain core.

Authors:  Elizabeth Stansell; Ewan Tytler; Mark R Walter; Eric Hunter
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Evidence that HIV budding in primary macrophages occurs through the exosome release pathway.

Authors:  Deborah Greene Nguyen; Amy Booth; Stephen J Gould; James E K Hildreth
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

8.  Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.

Authors:  Akira Ono; Eric O Freed
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.

Authors:  A S Reicin; S Paik; R D Berkowitz; J Luban; I Lowy; S P Goff
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

Review 10.  Lipid rafts: elusive or illusive?

Authors:  Sean Munro
Journal:  Cell       Date:  2003-11-14       Impact factor: 41.582

View more
  7 in total

1.  Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding.

Authors:  Ian B Hogue; Adam Hoppe; Akira Ono
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

2.  Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy.

Authors:  Anjali Joshi; Himanshu Garg; Sherimay Ablan; Eric O Freed; Kunio Nagashima; N Manjunath; Premlata Shankar
Journal:  Virology       Date:  2011-05-06       Impact factor: 3.616

3.  A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.

Authors:  Sook-Kyung Lee; Janera Harris; Ronald Swanstrom
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

4.  Efavirenz enhances HIV-1 gag processing at the plasma membrane through Gag-Pol dimerization.

Authors:  Sho Sudo; Hiyori Haraguchi; Yoko Hirai; Hiroyuki Gatanaga; Jun-ichi Sakuragi; Fumitaka Momose; Yuko Morikawa
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

5.  Functional analysis of Rift Valley fever virus NSs encoding a partial truncation.

Authors:  Jennifer A Head; Birte Kalveram; Tetsuro Ikegami
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

6.  FLIM FRET technology for drug discovery: automated multiwell-plate high-content analysis, multiplexed readouts and application in situ.

Authors:  Sunil Kumar; Dominic Alibhai; Anca Margineanu; Romain Laine; Gordon Kennedy; James McGinty; Sean Warren; Douglas Kelly; Yuriy Alexandrov; Ian Munro; Clifford Talbot; Daniel W Stuckey; Christopher Kimberly; Bertrand Viellerobe; Francois Lacombe; Eric W-F Lam; Harriet Taylor; Margaret J Dallman; Gordon Stamp; Edward J Murray; Frank Stuhmeier; Alessandro Sardini; Matilda Katan; Daniel S Elson; Mark A A Neil; Chris Dunsby; Paul M W French
Journal:  Chemphyschem       Date:  2011-02-17       Impact factor: 3.102

7.  Characterization and mutagenesis of Chinese hamster ovary cells endogenous retroviruses to inactivate viral particle release.

Authors:  Pierre-Olivier Duroy; Sandra Bosshard; Emanuel Schmid-Siegert; Samuel Neuenschwander; Ghislaine Arib; Philippe Lemercier; Jacqueline Masternak; Lucien Roesch; Flavien Buron; Pierre-Alain Girod; Ioannis Xenarios; Nicolas Mermod
Journal:  Biotechnol Bioeng       Date:  2019-11-12       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.